Metformin for Jelly Belly

This trial tests metformin, a common diabetes medication, to determine its effectiveness in treating pseudomyxoma peritonei (PMP), a rare condition often linked to tumors in the appendix. Researchers aim to discover if metformin can serve as a viable treatment for individuals with PMP who have tried other treatments like surgery and chemotherapy or have tumors that cannot be removed. This trial suits adults diagnosed with PMP related to appendiceal tumors who are not currently taking metformin for another condition. As a Phase 2 trial, the research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.

Research has shown that metformin is generally safe for use. It is often prescribed for diabetes and is known for its safety profile. Some individuals may experience stomach issues when starting metformin, but these symptoms typically improve over time.

There is a rare but serious risk of lactic acidosis with metformin, where lactic acid accumulates in the blood and can be dangerous. Monitoring for symptoms like unusual tiredness or muscle pain is important.

Most treatments for "jelly belly," or excess abdominal fat, focus on diet and exercise, often with added weight-loss medications like orlistat or phentermine. But metformin, a medication typically used for diabetes, is showing promise for this condition. Researchers are excited about metformin because it targets insulin sensitivity and glucose metabolism, which is a unique approach compared to traditional weight-loss drugs. Additionally, metformin is taken orally and has a long history of safety and tolerability in diabetic patients, making it a potentially attractive option for those looking to manage abdominal fat without significant side effects.

Research has shown that metformin is commonly used to manage diabetes by lowering blood sugar levels. One study found that it reduces the risk of developing diabetes by 31% compared to a placebo. Metformin also aids in weight control, with some individuals losing and maintaining a small amount of weight over time. Although primarily used for diabetes, metformin's effects on blood sugar and weight might benefit other conditions like pseudomyxoma peritonei (PMP), a rare cancer. In this trial, participants will receive metformin to explore its potential for treating PMP. While researchers continue to study its potential for this condition, its impact on metabolism appears promising.⁶⁷⁸⁹¹⁰